TY - JOUR
KW - Cprd
KW - HbA(1c)
KW - Pancreatic cancer
KW - Type 2 diabetes
KW - Weight
AU - A. Mueller
AU - C. Meier
AU - S. Jick
AU - C. Schneider
AD - Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland; Boston Collaborative Drug Surveillance Program, Lexington, MA, USA. Electronic address: christoph.meier@usb.ch.
Boston Collaborative Drug Surveillance Program, Lexington, MA, USA; Boston University School of Public Health, Boston, MA, USA.
AN - 35314354
BT - Pancreatology
DO - 10.1016/j.pan.2022.03.012
DP - NLM
ET - 2022/03/23
LA - eng
N1 - 1424-3911
Mueller, Alexandra M
Meier, Christoph R
Jick, Susan S
Schneider, Cornelia
Journal Article
Switzerland
Pancreatology. 2022 Mar 14:S1424-3903(22)00102-8. doi: 10.1016/j.pan.2022.03.012.
PY - 2022
SN - 1424-3903
T2 - Pancreatology
TI - Characterization of the deterioration of diabetes control in patients with a subsequent diagnosis of pancreatic cancer: A descriptive study
ER -